World's Best Scientists 2026 revealed!
Award Badge
Genetics
India
2025
Award Badge
Medicine
India
2025

D-Index & Metrics

Genetics

D-Index
108
Citations
64498
World Ranking
559
National Ranking
86

Medicine

D-Index
108
Citations
64524
World Ranking
5884
National Ranking
579

Research.com Recognitions

  • 2025 - Research.com Genetics in India Leader Award
  • 2025 - Research.com Medicine in India Leader Award
  • 2024 - Research.com Genetics in India Leader Award
  • 2023 - Research.com Genetics in India Leader Award

Overview

Nazneen Rahman is affiliated with Kuvempu University in India and conducts research primarily in the fields of Biochemistry, Genetics and Molecular Biology, and Medicine. Their work focuses extensively on Genetics and Molecular Biology, with additional interests in Pulmonary and Respiratory Medicine, Cancer Research, and Oncology.

Their main research topics include:

  • BRCA gene mutations in cancer
  • Genomics and Rare Diseases
  • Cancer Genomics and Diagnostics
  • Genomic variations and chromosomal abnormalities
  • PARP inhibition in cancer therapy
  • CRISPR and Genetic Engineering
  • RNA Research and Splicing

Important publication venues for their work include:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • UNC Libraries
  • SSRN Electronic Journal
  • Genetics in Medicine
  • Scientific Reports

Recent notable papers authored or co-authored by Rahman are:

  • One in seven pathogenic variants can be challenging to detect by NGS: an analysis of 450,000 patients with implications for clinical sensitivity and genetic test implementation, 2021, Genetics in Medicine
  • Oncologist-led BRCA 'mainstreaming' in the ovarian cancer clinic: A study of 255 patients and its impact on their management, 2020, Scientific Reports
  • Chromosomal instability by mutations in the novel minor spliceosome component CENATAC, 2021, The EMBO Journal
  • One in seven pathogenic variants can be challenging to detect by NGS: An analysis of 450,000 patients with implications for clinical sensitivity and genetic test implementation, 2020, bioRxiv (Cold Spring Harbor Laboratory)
  • MCF classifier: Estimating, standardizing, and stratifying medicine carbon footprints, at scale, 2024, British Journal of Clinical Pharmacology

Frequent co-authors who have collaborated with Rahman include:

  • Shazia Mahamdallie (four publications)
  • Sheila Seal (three publications)
  • H. A. Taylor (three publications)
  • Pratistha Panday (three publications)
  • James Nicholson (three publications)

Best Publications

  • Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls

    Paul R. Burton;David G. Clayton;Lon R. Cardon;Nick Craddock

  • A census of human cancer genes

    P. Andrew Futreal;Lachlan Coin;Mhairi Marshall;Thomas Down

  • Genome-wide association study identifies novel breast cancer susceptibility loci

    Douglas F. Easton;Karen A. Pooley;Alison M. Dunning;Paul D. P. Pharoah

  • Modeling Linkage Disequilibrium Increases Accuracy of Polygenic Risk Scores

    Bjarni J. Vilhjálmsson;Jian Yang;Hilary K. Finucane;Alexander Gusev

  • Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants

    Paul R Burton;David G Clayton;Lon R Cardon;Nick Craddock

  • Association analysis identifies 65 new breast cancer risk loci

    Kyriaki Michailidou;Kyriaki Michailidou;Sara Lindström;Sara Lindström;Joe Dennis;Jonathan Beesley

  • Low-penetrance susceptibility to breast cancer due to CHEK2(*)1100delC in noncarriers of BRCA1 or BRCA2 mutations

    Hanne Meijers-Heijboer;Ans van den Ouweland;Jan Klijn;Marijke Wasielewski

  • Large-scale genotyping identifies 41 new loci associated with breast cancer risk

    Kyriaki Michailidou;Per Hall;Anna Gonzalez-Neira;Maya Ghoussaini

  • PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene

    Nazneen Rahman;Sheila Seal;Deborah Thompson;Patrick Kelly

  • A structural variation reference for medical and population genetics

    Ryan L Collins;Ryan L Collins;Harrison Brand;Harrison Brand;Konrad J Karczewski;Konrad J Karczewski;Xuefang Zhao;Xuefang Zhao

  • Prevalence of BRCA1 and BRCA2 Gene Mutations in Patients With Early-Onset Breast Cancer

    Julian Peto;Nadine Collins;Rita Barfoot;Sheila Seal

  • Breast-Cancer Risk in Families with Mutations in PALB2

    A. C. Antoniou;S. Casadei;T. Heikkinen;D. Barrowdale

  • Gene-Panel Sequencing and the Prediction of Breast-Cancer Risk

    Douglas Frederick Easton;Paul David Pharoah;Antonis C. Antoniou;Marc Derek Tischkowitz

  • Genome-wide association study of CNVs in 16,000 cases of eight common diseases and 3,000 shared controls

    Nick Craddock;Matthew E. Hurles;Niall Cardin;Richard D. Pearson

  • ATM mutations that cause ataxia-telangiectasia are breast cancer susceptibility alleles

    Anthony Renwick;Deborah Thompson;Sheila Seal;Patrick Kelly

  • Genome-wide association study identifies five new breast cancer susceptibility loci

    Clare Turnbull;Shahana Ahmed;Jonathan Morrison;David Pernet

  • Truncating mutations in the Fanconi anemia J gene BRIP1 are low-penetrance breast cancer susceptibility alleles

    Sheila Seal;Deborah Thompson;Anthony Renwick;Anna Elliott

  • Carboplatin in BRCA1/2-mutated and triple-negative breast cancer BRCAness subgroups: The TNT Trial

    Andrew Tutt;Andrew Tutt;Holly Tovey;Maggie Chon U Cheang;Sarah Kernaghan

  • Biallelic mutations in PALB2 cause Fanconi anemia subtype FA-N and predispose to childhood cancer

    Sarah Reid;Detlev Schindler;Helmut Hanenberg;Helmut Hanenberg;Karen Barker

  • Realizing the promise of cancer predisposition genes.

    Nazneen Rahman

Frequent Co-Authors

Sheila Seal
Sheila Seal Institute of Cancer Research
Michael R. Stratton
Michael R. Stratton Wellcome Sanger Institute
Douglas F. Easton
Douglas F. Easton University of Cambridge
Clare Turnbull
Clare Turnbull Institute of Cancer Research
Graham G. Giles
Graham G. Giles University of Melbourne
Melissa C. Southey
Melissa C. Southey Monash University
John L. Hopper
John L. Hopper University of Melbourne
Hiltrud Brauch
Hiltrud Brauch German Cancer Research Center
Jenny Chang-Claude
Jenny Chang-Claude German Cancer Research Center
Diana Eccles
Diana Eccles University of Southampton

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring genetics in the USA often leads students to consider diverse allied fields in healthcare and science. For those interested in hands-on patient care, nursing schools without teas test requirements offer an accessible entry point. These programs allow students to pursue a nursing career without the need for standardized entrance exams, streamlining the application process.

Management roles in healthcare are also in high demand. If you envision leading organizations or developing healthcare policy, affordable mha online programs can prepare you for impactful roles in administration. Flexible online formats also let you balance studies with other commitments.

Those looking for a quicker route into the nursing profession might be interested in fast track lpn programs online. These programs provide an accelerated pathway to licensing and workforce entry, making them ideal for career changers or those eager to start working.

Finally, for professionals seeking the highest level of nursing education, online nursing doctoral programs can open doors to research, academia, or executive roles.

Best Scientists Citing Nazneen Rahman

Trending Scientists